Browse 6,000+ US-traded stocks with real-time quotes, AI-powered analysis, options flow intelligence, earnings predictions, and multi-signal convergence detection. Filter by sector, market cap, price range, and signal strength to find stocks matching your investment criteria.
What You Get
Real-time stock quotes from a 5-source consensus pricing engine
AI analysis with buy/sell/hold signals backed by 12 independent indicators
Options flow tracking — unusual activity, put/call ratios, and open interest anomalies
Earnings predictions with historical beat rates and EPS estimates
Convergence scanner detecting when multiple signals align on a single stock
Sector and industry filtering across all 11 GICS sectors
Frequently Asked Questions
Is the stock screener free?
Yes, iGotFomo provides completely free access to real-time stock data, AI analysis, and all screening tools with no account required.
How many stocks are covered?
Over 6,000 US-traded stocks including all NYSE, NASDAQ, and AMEX listings. Data is updated in real-time during market hours.
DMAA Stock Price Today $10.49 (+0.19%) ▲
About Drugs Made In America Acquisiti (DMAA)
Drugs Made In America Acquisiti (DMAA) is a publicly traded company in the Financial Services sector, specifically in the Shell Companies industry. View real-time stock data, AI analysis, options flow, and convergence signals for DMAA on iGotFomo.
Drugs Made In America Acquisiti (DMAA) is a publicly traded company in the Financial Services sector, operating in the Shell Companies industry.
What is the current DMAA stock price?
As of the latest trading session, DMAA trades at $10.49 per share, with a daily change of +0.19%.
What is DMAA's market capitalization?
Drugs Made In America Acquisiti has a market capitalization of $352 million, making it a small-cap stock.
What sector does DMAA belong to?
Drugs Made In America Acquisiti operates in the Financial Services sector, specifically in the Shell Companies industry. View all Financial Services stocks.